PHAT
Phathom Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.68
−1.05%Leverage
- Debt / equity
- -0.48x
- Net debt / equity
- 0.05x
- Debt / assets
- 0.49x
- Debt / EBITDA
- -8.47x
- Net debt / EBITDA
- 0.84x
Liquidity & coverage
- Current ratio
- 1.76x
- Quick ratio
- 1.72x
- Cash ratio
- 1.06x
- Interest coverage
- -0.41x
- EBITDA / interest
- -0.32x
- Working capital
- $133.1M
Cash & dividend
- FCF / debt
- -0.12x
- Cash flow / debt
- -0.12x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026